Results 81 to 90 of about 66,314 (265)

Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin. [PDF]

open access: yes, 2018
info:eu-repo/semantics ...
Chambel, M   +5 more
core   +1 more source

Safety and Tolerability of a 3‐h Build‐Up Phase With Hymenoptera Venom Depot Extracts: Preliminary Results

open access: yes
Allergy, EarlyView.
Alessandro Buonomo   +6 more
wiley   +1 more source

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

open access: yesTransplant Infectious Disease, EarlyView.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio   +7 more
wiley   +1 more source

[Systemic mastocytosis].

open access: yesMedicina cutanea ibero-latino-americana, 1989
213
Almagro Sanchez, M.   +4 more
openaire   +2 more sources

Baseline Serum Tryptase: Sex‐ and Age‐Specific Reference Intervals in the Pediatric and Adult Population

open access: yes
Allergy, EarlyView.
Yannick Chantran   +17 more
wiley   +1 more source

Granulocyte Transfusions in Pediatric Hemato‐Oncology: Neutrophil Response and CRP Kinetics

open access: yesPediatric Blood &Cancer, Volume 72, Issue 11, November 2025.
ABSTRACT Background Granulocyte transfusions (GTXs) are used in neutropenic pediatric hemato‐oncology patients with infections unresponsive to antimicrobial therapy, but their clinical benefit remains uncertain. Methods We retrospectively reviewed all pediatric patients who received GTXs between 2013 and 2023 at a tertiary medical center.
Aviv Sever   +9 more
wiley   +1 more source

Systemic Mastocytosis Presenting as Acute Appendicitis: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology, 2013
Systemic mastocytosis is characterized by abnormal growth and accumulation of mast cells in various organs. Gastrointestinal (GI) symptoms are common disease manifestations in this disease and can significantly impair the quality of life.
Syed A. Akbar   +4 more
doaj   +1 more source

Human Skin/SCID Mouse Chimeras as an In Vivo Model for Human Cutaneous Mast Cell Hyperplasia [PDF]

open access: yes, 1997
Human skin xenografted to mice with severe combined immunodeficiency syndrome (SCID) was evaluated to determine the integrity and fate of human dermal mast cells.
Melpo Christofidou-Solomidou   +42 more
core   +1 more source

Challenges in Extrapolating Healthy Volunteer Pharmacokinetics to Oncology Populations: Advocating for a Holistic Perspective

open access: yesClinical and Translational Science, Volume 18, Issue 11, November 2025.
ABSTRACT Phase I clinical pharmacology (CP) studies in healthy volunteers (HVs) are conducted to assess factors influencing drug pharmacokinetic (PK) properties and guide potential dose adjustments or restrictions for specific subpopulations within the target patient population.
Yan Ji   +2 more
wiley   +1 more source

Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms [PDF]

open access: yes, 2015
Myeloproliferative neoplasms (MPN) are a diverse group of chronic hematological disorders that involve unregulated clonal proliferation of white blood cells.
Kapur, Reuben, Pandey, Ruchi
core   +1 more source

Home - About - Disclaimer - Privacy